ProKidney Corp.

For some patients, progression in #CKD can mean dialysis becoming part of long-term care. That shift can change how care is structured and how daily life is organized around treatment. Progression isn’t just clinical — it’s also structural. #KidneyMonth

ProKidney was honored to receive the Market Innovation Award at the @nkfcarolinas' #WorldKidneyDay Reception! We're grateful to the kidney community working together to advance innovation for people living with kidney disease. #HealthcareInnovation

As chronic kidney disease progresses, care often becomes more complex. Many patients manage multiple conditions at once, and that overlap can influence risk and long-term outcomes. #CKD is rarely isolated to one diagnosis. #KidneyMonth

Chronic kidney disease isn’t just about kidney function. As it progresses, it can influence hospitalization risk, metabolic stability, and long-term outcomes. #CKD doesn’t stay confined to one organ. This #KidneyMonth, we’re looking beyond the kidney. #KidneyHealth

Our CEO Bruce Culleton is featured in the @KidneyPatients Innovator Series. He shares what first drew him to kidney care, why preserving kidney function matters, and how patient voices shape innovation in #CKD. Read the Q&A: bit.ly/4rRYBfS #KidneyDisease #Innovation

As we enter National Kidney Month, our mission continues: investigating new approaches for Stage 3b/4 #CKD + #T2D. Stay tuned for more insights on our Phase 3 progress. $PROK

To #CKD caregivers: your dedication makes a difference. This #NationalCaregiversDay, we honor those supporting loved ones through the complex journey of kidney disease. Thank you.

From past breakthroughs to today’s challenges, advances in kidney care are shaped by the pioneers who paved the way. 🎥 Learn more about leaders who helped shape kidney transplantation and the ongoing need to advance kidney care. #BlackHistoryMonth #KidneyHealth #CKD

The heart-kidney connection is crucial in #CKD. As we investigate new approaches for Stage 3b/4 CKD + type 2 diabetes, cardiovascular impact remains key. Learn more about our Phase 3 #ClinicalTrial: HopeForCKD.com #AmericanHeartMonth

This #NationalDonorDay, we honor organ donors while working toward earlier interventions. Our mission: investigating ways to preserve kidney function and potentially delay/prevent the need for dialysis. #CKD

Rilparencel: Investigating a personalized approach using a patient's own kidney cells. First autologous cell therapy in Phase 3 for advanced #CKD + #T2D. Learn more: HopeForCKD.com $PROK

Kidney + heart health are deeply connected — when kidneys decline, cardiovascular risk rises. For #AmericanHeartMonth, we're exploring the kidney-heart connection and why preservation of kidney function matters for whole-patient health. #CKD

Advancing a first-of-its-kind cell therapy in #CKD starts with people. Today, we’re celebrating teammates who’ve been promoted into new roles at ProKidney. Thank you for raising the bar for patients, partners and colleagues. #TeamProKidney #BiotechCareers

#DYK that 1 in 3 U.S. adults are at risk for kidney disease? Spend 1 minute to take @nkf’s Kidney Risk Quiz and learn your risk. Early detection can save lives: kidney.org/kidney-quiz/ #KidneyHealth #CKD #EarlyDetection #MinuteForYourKidneys

On #MLKDay, we reflect on how health equity must shape clinical research. ProKidney is committed to advancing kidney care by ensuring our trials reach the communities most affected by #CKD. #HealthEquity #ClinicalResearch

ProKidney is developing a personalized cell therapy for advanced #CKD — using a patient’s own kidney cells, with no gene editing or viral vectors. In-house manufacturing enables scale. Learn more: bit.ly/4sD8ZZA #CellTherapy #KidneyHealth

Ahead of #JPM2026, we’re focused on advancing our late-stage #CKD program, strengthening commercial readiness, and continuing our mission to support high-risk CKD patients. Learn more: bit.ly/4qG0lYv #HealthcareInnovation

#News: @Inside_PM profiles CEO Bruce Culleton, M.D. and the mission guiding ProKidney’s work in #CKD. Read more: bit.ly/4p7DiVr #CellTherapy #KidneyHealth

CEO Bruce Culleton, M.D. joins the Business of Biotech podcast to discuss his journey from practicing nephrologist to biotech CEO and how ProKidney is working to advance treatment options for people living with #CKD. 🎧 Listen: bit.ly/4pRQQ8s #Biotech #Leadership

We close 2025 with gratitude — and enter 2026 focused on what’s ahead for kidney care. Thank you and happy holidays from all of us at ProKidney.